See how Ergomed’s Phase III Clinical Trial for Locally Advanced Squamous Cell Head & Neck Carcinoma (SCCHN) tackled one of the largest head and neck cancer studies globally. With 928 patients across 120+ sites in North America, Europe, and Asia, this Rescue study faced challenges in enrollment, complex site coordination, and integrating diverse standards of … Continued